Healthcare Trust of America Inc. (NYSE:HTA) shares reached a new 52-week high on Friday . The company traded as high as $33.25 and last traded at $33.21, with a volume of 121,357 shares changing hands. The stock had previously closed at $32.95.

A number of research analysts recently weighed in on HTA shares. Stifel Nicolaus raised their price target on shares of Healthcare Trust of America from $29.00 to $31.00 and gave the company a “buy” rating in a research report on Tuesday, April 26th. Wunderlich reissued a “hold” rating and set a $28.50 price target (up from $25.00) on shares of Healthcare Trust of America in a research report on Wednesday, April 27th. Finally, Zacks Investment Research lowered shares of Healthcare Trust of America from a “hold” rating to a “sell” rating in a research report on Monday. One research analyst has rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $29.39.

The firm has a 50-day moving average of $31.90 and a 200-day moving average of $29.33. The firm has a market capitalization of $4.55 billion and a PE ratio of 117.70.

Healthcare Trust of America (NYSE:HTA) last released its earnings results on Monday, April 25th. The real estate investment trust reported $0.40 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.40. The business earned $107.30 million during the quarter, compared to analysts’ expectations of $103.72 million. During the same period in the prior year, the company earned $0.37 earnings per share. The firm’s quarterly revenue was up 8.9% compared to the same quarter last year. Analysts expect that Healthcare Trust of America Inc. will post $1.62 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, July 8th. Stockholders of record on Friday, July 1st were given a $0.295 dividend. This represents a $1.18 dividend on an annualized basis and a dividend yield of 3.58%. The ex-dividend date of this dividend was Wednesday, June 29th.

Other hedge funds have added to or reduced their stakes in the company. ProShare Advisors LLC increased its stake in Healthcare Trust of America by 11.9% in the fourth quarter. ProShare Advisors LLC now owns 45,902 shares of the real estate investment trust’s stock worth $1,238,000 after buying an additional 4,876 shares in the last quarter. State Board of Administration of Florida Retirement System increased its stake in Healthcare Trust of America by 6.5% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 46,271 shares of the real estate investment trust’s stock worth $1,248,000 after buying an additional 2,818 shares in the last quarter. Cornerstone Capital Management Holdings LLC. increased its stake in Healthcare Trust of America by 2.0% in the fourth quarter. Cornerstone Capital Management Holdings LLC. now owns 74,211 shares of the real estate investment trust’s stock worth $2,001,000 after buying an additional 1,472 shares in the last quarter. Rhumbline Advisers increased its stake in Healthcare Trust of America by 2.1% in the fourth quarter. Rhumbline Advisers now owns 87,833 shares of the real estate investment trust’s stock worth $2,369,000 after buying an additional 1,835 shares in the last quarter. Finally, Sei Investments Co. increased its stake in Healthcare Trust of America by 186.4% in the fourth quarter. Sei Investments Co. now owns 103,369 shares of the real estate investment trust’s stock worth $2,788,000 after buying an additional 67,277 shares in the last quarter.

Healthcare Trust of America, Inc (HTA) operates as a real estate investment trust (REIT). The Company operates through investing in healthcare real estate assets segment. The primary objective is to generate stockholder value through consistent and growing dividends and appreciation of real estate value.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.